Short-Form McGill Pain Questionnaire (SF-MPQ)

Overview

The Short-Form McGill Pain Questionnaire (SF-MPQ) is one of the most widely used and scientifically validated multidimensional self-report instruments for assessing pain. Developed by Ronald Melzack (1987) as a concise version of the original McGill Pain Questionnaire, the SF-MPQ provides a rapid yet comprehensive evaluation of the sensory, affective, and overall intensity of pain. Its brief administration time, ease of use, and excellent psychometric performance have established it as a gold-standard instrument for both clinical practice and research, particularly in the assessment of acute and chronic pain across diverse patient populations.

Objective

The primary objective of the Short-Form McGill Pain Questionnaire (SF-MPQ) is to provide a comprehensive assessment of the multidimensional pain experience, integrating both the qualitative characteristics and quantitative intensity of pain. The instrument facilitates clinical evaluation, treatment monitoring, and research by capturing sensory and emotional aspects of pain while supporting evidence-based therapeutic decision-making.

Specifically, the SF-MPQ is designed to:

  • Assess the sensory and affective dimensions of pain.
  • Measure current pain intensity and overall pain severity.
  • Monitor changes in pain over time and evaluate treatment effectiveness.
  • Compare the efficacy of pharmacological and non-pharmacological interventions.
  • Support clinical diagnosis and research involving acute and chronic pain conditions.

Scale Structure

The SF-MPQ consists of 17 assessment components, including 15 pain descriptors and two global pain intensity measures.

The questionnaire includes:

  • 11 sensory descriptors, evaluating the physical characteristics of pain.
  • 4 affective descriptors, assessing the emotional aspects of the pain experience.

Each descriptor is rated on a 4-point Likert scale:

  • 0 = None
  • 1 = Mild
  • 2 = Moderate
  • 3 = Severe

In addition, the SF-MPQ incorporates two complementary measures:

  • Present Pain Intensity (PPI), rated on a 6-point scale (0–5).
  • Visual Analogue Scale (VAS), consisting of a 100-mm horizontal line on which patients indicate their current pain intensity.

The integration of these three measures provides a comprehensive and multidimensional evaluation of pain perception.

Applications

The Short-Form McGill Pain Questionnaire is extensively used in pain medicine, anesthesiology, rehabilitation, oncology, rheumatology, neurology, orthopedics, psychology, and clinical research. It is considered one of the standard outcome measures for evaluating patients with both acute and chronic pain conditions.

Clinically, the SF-MPQ is employed to assess pain severity, monitor disease progression, and evaluate responses to pharmacological, surgical, psychological, and rehabilitative interventions. In research, it has been widely applied in studies involving musculoskeletal pain, neuropathic pain, cancer-related pain, rheumatic diseases, postoperative recovery, fibromyalgia, and chronic pain syndromes, making it one of the most frequently cited pain assessment instruments worldwide.

Scoring and Psychometric Evaluation

The SF-MPQ generates three principal scores:

  • Sensory Pain Rating Index (PRI-Sensory).
  • Affective Pain Rating Index (PRI-Affective).
  • Total Pain Rating Index (PRI-Total).

These scores are derived from the sum of the 15 pain descriptors. In parallel, the Present Pain Intensity (PPI) and Visual Analogue Scale (VAS) are analyzed independently to provide complementary measures of current pain severity.

The psychometric evaluation of the SF-MPQ includes assessments of internal consistency (Cronbach’s α), construct validity, criterion validity, and responsiveness to clinical change. The instrument has been translated and validated in numerous languages, including Greek, where the version developed by Georgoudis, Watson, and Oldham demonstrated satisfactory psychometric properties. Although the uploaded document confirms the excellent reliability and validity of the Greek version, it does not report specific numerical indices (e.g., Cronbach’s α coefficients or factor loadings), and therefore no exact psychometric values can be presented.

Interpretation

Higher PRI, PPI, and VAS scores indicate greater pain severity and a more pronounced impact on physical and emotional functioning. The VAS is commonly interpreted as follows:

  • 0–4 mm: No pain
  • 5–44 mm: Mild pain
  • 45–74 mm: Moderate pain
  • 75–100 mm: Severe pain

By integrating sensory descriptors, affective descriptors, current pain intensity, and global pain severity, the SF-MPQ provides clinicians and researchers with a robust multidimensional profile of the patient’s pain experience, enabling accurate diagnosis, individualized treatment planning, and longitudinal monitoring of therapeutic outcomes.

References

Melzack, R. (1987). The Short-Form McGill Pain Questionnaire. Pain, 30(2), 191–197.

Georgoudis, G., Watson, P. J., & Oldham, J. A. (2000). The Development and Validation of a Greek Version of the Short-Form McGill Pain Questionnaire. European Journal of Pain, 4, 275–281.